Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | %Female (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | American Journal of Clinical Oncology: Cancer Clinical Trials | journal | 0.900 Q3 | 90 | 110 | 347 | 3403 | 824 | 334 | 2.15 | 30.94 | 32.81 | |
52 | Clinical Lymphoma, Myeloma and Leukemia | journal | 0.890 Q3 | 65 | 124 | 300 | 3566 | 589 | 278 | 1.96 | 28.76 | 37.29 | |
53 | European Journal of Cancer Prevention | journal | 0.864 Q3 | 88 | 89 | 222 | 3175 | 571 | 220 | 2.40 | 35.67 | 43.08 | |
54 | Cancer Genetics and Cytogenetics | journal | 0.815 Q3 | 78 | 0 | 639 | 0 | 931 | 524 | 1.38 | 0.00 | 0.00 | |
55 | Current Hematologic Malignancy Reports | journal | 0.681 Q3 | 44 | 34 | 90 | 1566 | 149 | 90 | 2.16 | 46.06 | 40.00 | |
56 | Technology in Cancer Research and Treatment | journal | 0.669 Q3 | 72 | 64 | 184 | 2148 | 391 | 174 | 2.02 | 33.56 | 24.79 | |
57 | Oncology Research | journal | 0.654 Q3 | 76 | 33 | 144 | 1308 | 246 | 142 | 1.60 | 39.64 | 33.16 | |
58 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.650 Q3 | 68 | 86 | 261 | 3784 | 560 | 251 | 2.15 | 44.00 | 39.08 | |
59 | Medical Oncology | journal | 0.641 Q3 | 90 | 355 | 404 | 9693 | 648 | 394 | 1.57 | 27.30 | 37.72 | |
60 | Journal of Experimental Therapeutics and Oncology | journal | 0.604 Q3 | 40 | 31 | 63 | 973 | 126 | 61 | 1.55 | 31.39 | 38.46 | |
61 | Current Problems in Cancer | journal | 0.591 Q3 | 47 | 28 | 60 | 1200 | 70 | 39 | 1.16 | 42.86 | 45.00 | |
62 | Critical Reviews in Oncogenesis | journal | 0.574 Q3 | 57 | 21 | 27 | 1628 | 27 | 19 | 2.00 | 77.52 | 44.44 | |
63 | Oncology | journal | 0.490 Q3 | 83 | 306 | 652 | 3678 | 508 | 489 | 0.84 | 12.02 | 31.80 | |
64 | Hormones and Cancer | journal | 0.310 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
65 | Journal of Cancer Science and Therapy (discontinued) | journal | 0.255 Q4 | 22 | 64 | 32 | 2199 | 92 | 32 | 2.88 | 34.36 | 40.80 | |
66 | Cancer Therapy | journal | 0.252 Q4 | 9 | 3 | 65 | 159 | 35 | 65 | 0.54 | 53.00 | 30.00 | |
67 | National Toxicology Program technical report series | journal | 0.239 | 22 | 8 | 22 | 0 | 18 | 22 | 0.53 | 0.00 | 0.00 | |
68 | Annals of Cancer Research and Therapy | journal | 0.133 Q4 | 7 | 10 | 37 | 223 | 4 | 35 | 0.08 | 22.30 | 10.45 | |
69 | Cancer genetics | journal | 52 | 98 | 0 | 3603 | 0 | 0 | 0.00 | 36.77 | 45.05 | ||
70 | Cancer Immunology Research | journal | 134 | 3 | 38 | 79 | 175 | 35 | 4.45 | 26.33 | 33.33 | ||
71 | Cancer journal (Sudbury, Mass.) | journal | 102 | 74 | 259 | 4681 | 955 | 226 | 3.56 | 63.26 | 30.53 | ||
72 | Current Cancer Research | book series | 8 | 32 | 0 | 3724 | 0 | 0 | 0.00 | 116.38 | 32.47 | ||
73 | Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis | journal | 59 | 12 | 36 | 1557 | 242 | 36 | 6.36 | 129.75 | 38.64 | ||
74 | NTP Technical Report on the Toxicity Studies Series | book series | 6 | 2 | 0 | 186 | 0 | 0 | 0.00 | 93.00 | 32.00 | ||
75 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 8 | 22 | 911 | 0 | 22 | 0.00 | 113.88 | 35.42 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®